BrainsWay Stock: Building A Capital-Light Interventional Psychiatry Ecosystem (BWAY)
· seekingalpha.com
BrainsWay (BWAY) Q1-2026 stock update: TMS growth, recurring revenue shift, FY-2026 outlook, and valuation risks. See more details here.
I currently see BrainsWay ( BWAY ) as a company moving beyond the clinical differentiation of its Deep Transcranial Magnetic Stimulation (Deep TMS) technology. ...